Korea Investment CORP Lowers Holdings in Danaher Corporation (DHR)
Korea Investment CORP reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 6.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 297,814 shares of the company’s stock after selling 21,014 shares during the period. Korea Investment CORP’s holdings in Danaher Corporation were worth $25,546,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of DHR. GQG Partners LLC purchased a new stake in shares of Danaher Corporation in the second quarter valued at about $101,000. Proficio Capital Partners LLC boosted its holdings in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the company’s stock worth $105,000 after buying an additional 598 shares in the last quarter. Monetary Management Group Inc. boosted its holdings in Danaher Corporation by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the company’s stock worth $131,000 after buying an additional 150 shares in the last quarter. Acrospire Investment Management LLC boosted its holdings in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the company’s stock worth $143,000 after buying an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter worth about $157,000. 75.38% of the stock is currently owned by institutional investors.
In other Danaher Corporation news, insider William King sold 43,688 shares of the stock in a transaction on Thursday, August 31st. The shares were sold at an average price of C$82.86, for a total transaction of C$3,619,987.68. Following the sale, the insider now directly owns 45,748 shares of the company’s stock, valued at C$3,790,679.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of C$92.64, for a total transaction of C$11,671,620.96. Following the sale, the chief executive officer now directly owns 271,737 shares in the company, valued at C$25,173,715.68. The disclosure for this sale can be found here. Insiders have sold 279,628 shares of company stock worth $25,304,394 over the last three months. 12.20% of the stock is owned by corporate insiders.
A number of analysts recently commented on DHR shares. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a report on Friday, August 4th. Zacks Investment Research raised shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a report on Thursday, October 5th. Cowen and Company restated a “buy” rating and set a $90.00 target price on shares of Danaher Corporation in a research report on Wednesday, October 4th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, BidaskClub upgraded shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of C$93.31.
Shares of Danaher Corporation (NYSE:DHR) opened at C$92.24 on Monday. The stock has a market cap of $64,162.62, a price-to-earnings ratio of 23.71, a P/E/G ratio of 2.19 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. Danaher Corporation has a twelve month low of C$76.27 and a twelve month high of C$93.36.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 19th. The company reported C$1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of C$0.95 by C$0.05. The firm had revenue of C$4.53 billion for the quarter, compared to analysts’ expectations of C$4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.87 earnings per share. equities analysts predict that Danaher Corporation will post 3.99 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were issued a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. Danaher Corporation’s dividend payout ratio (DPR) is 16.52%.
COPYRIGHT VIOLATION WARNING: “Korea Investment CORP Lowers Holdings in Danaher Corporation (DHR)” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.watchlistnews.com/korea-investment-corp-lowers-holdings-in-danaher-corporation-dhr/1699656.html.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.